Preoperative chemotherapy for T2 breast cancer is associated with improved surgical outcome


Karanlik H. , Özgür I. , Cabioglu N. , Sen F., Erturk K. , Kilic B., ...More

EJSO, vol.41, no.9, pp.1226-1233, 2015 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 41 Issue: 9
  • Publication Date: 2015
  • Doi Number: 10.1016/j.ejso.2015.06.003
  • Title of Journal : EJSO
  • Page Numbers: pp.1226-1233
  • Keywords: Preoperative chemotherapy, Breast cancer, T2 breast tumor, 20-YEAR FOLLOW-UP, CONSERVING SURGERY, NEOADJUVANT CHEMOTHERAPY, CONSERVATION THERAPY, TUMOR SIZE, AESTHETIC EVALUATION, LOCAL RECURRENCE, ADJUVANT BREAST, MARGIN STATUS, CARCINOMA

Abstract

Background: The aim of this study is to compare the clinical outcome in T2 breast cancer patients who underwent preoperative chemotherapy (PC) and who did not. The study also tried to define a subgroup of patients, who are more beneficial after PC in terms of lower re-excision rates, better cosmetic results and local recurrence free survival.